RETRACTED: Effects of CDKN2A (p16INK4A/p14ARF) Over-Expression on Proliferation and Migration of Human Melanoma A375 Cells (Retracted Article)

OBJECTIVE: This study aims to investigate the effects of CDKN2A (p16(INK4A)/p14(ARF)) over-expression on the proliferation and migration of human melanoma A375 cells. METHODS: Melanoma tissues and pigmented nevi tissues were collected. Human melanoma A375 cells were transfected by CDKN2A (p16(INK4A)) and CDKN2A (p14(ARF)) over-expressing vectors and then assigned into blank, negative control (NC), p16(INK4A) and p14(ARF) groups. The expression of CDKN2A (p16(INK4A)) and CDKN2A (p14(ARF)) mRNA and protein was detected by qRT-PCR and Western blotting. CCK-8, flow cytometry and Transwell assays were applied to observe cell proliferation, the cell cycle and apoptosis, and migration and invasion, respectively. The model of subcutaneous xenografts in nude mice was established to measure cell growth in vivo. RESULTS: Compared with pigmented nevi tissues, CDKN2A (p16(INK4A)) and CDKN2A (p14(ARF)) mRNA and protein expression were significantly decreased in melanoma tissues. CDKN2A (p16(INK4A)) and CDKN2A (p14(ARF)) over-expression inhibited proliferation, migration, invasion and progression from G0/G1 to S phase of A375 cells and xenograft tumor growth, but promoted apoptosis. CONCLUSION: Our study demonstrated that over-expression of CDKN2A (p16(INK4A)) and CDKN2A (p14(ARF)) suppressed proliferation and migration of human melanoma A375 cells. (C) 2016 The Author(s) Published by Karger AG, Basel